Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:Commentary: Let the Time Fly: Dopamine is the Arbiter
Volume: 17 Issue: 1
Author(s): Xiaodong Liu, Changzheng Zhang, Oscar Arias-Carrion* Ti-Fei Yuan*
Affiliation:
- Trastornos del Movimiento y Sueno, Hospital General Dr. Manuel Gea Gonzalez, Ciudad de Mexico,Mexico
- Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai,China
Export Options
About this article
Cite this article as:
Liu Xiaodong, Zhang Changzheng, Arias-Carrion Oscar *, Yuan Ti-Fei *, Commentary: Let the Time Fly: Dopamine is the Arbiter, CNS & Neurological Disorders - Drug Targets 2018; 17 (1) . https://dx.doi.org/10.2174/1871527316999170505110106
DOI https://dx.doi.org/10.2174/1871527316999170505110106 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Hypothermia for Cardiopulmonary Resuscitation: Why, When and How
Current Cardiology Reviews subject Index To Volume 2
Current Molecular Medicine Exploring the Potential of Neuroproteomics in Alzheimer's Disease
Current Topics in Medicinal Chemistry Impact of Covid-19 on Mental Health: An Overview
Reviews on Recent Clinical Trials Editorial (Thematic issue: “Alkaloids in Nature: Synthesis, Isolation and Pharmacological Applications” Part 1)
Current Topics in Medicinal Chemistry In Silico Analysis of Binding Interaction of Mamba Toxins with M4 and M2 Muscarinic Acetylcholine Receptors for Therapeutic Use in Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Pharmacologic Treatment of Restless Legs Syndrome
Current Neuropharmacology Analyzing of Molecular Networks for Human Diseases and Drug Discovery
Current Topics in Medicinal Chemistry Exploring the Role of “Brahmi” (Bacopa monnieri and Centella asiatica) in Brain Function and Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Drugs and Rhabdomyolysis: From Liver to Kidney
Current Vascular Pharmacology Pharmacotherapy for Smoking Cessation: Present and Future
Current Pharmaceutical Design Smooth Muscle Cell Pathophysiology and Advanced Glycation End Products (AGEs)
Current Drug Targets Meet Our Editorial Board Member
Current Alzheimer Research Strategies for the Recruitment and Retention of Racial/Ethnic Minorities in Alzheimer Disease and Dementia Clinical Research
Current Alzheimer Research Migraine Attack Treatment : A Tailor-made Suit, Not One Size Fits All
Recent Patents on CNS Drug Discovery (Discontinued) Anticonvulsant Action and Long-term Effects of Gabapentin
Current Neuropharmacology Multitarget Cannabinoids as Novel Strategy for Alzheimer Disease
Current Alzheimer Research Integrating Pathophysiology in Migraine: Role of the Gut Microbiome and Melatonin
Current Pharmaceutical Design T-Type Calcium Channels and Thalamocortical Rhythms in Sleep: A Perspective from Studies of T-Type Calcium Channel Knockout Mice
CNS & Neurological Disorders - Drug Targets Systemic Sclerosis: Clinical Manifestations
Current Rheumatology Reviews